Robert Kurzeja is a Preclinical Research Senior Manager at A2 Biotherapeutics, Inc., where they have been since 2022. Previously, Robert worked at Abbott Laboratories from 1997 to 1998 as a Research Biochemist, contributing to drug discovery projects in various pharmaceutical targets. Their extensive career at Amgen spanned multiple positions in the Protein Technologies and Discovery Research divisions, where they advanced from Associate Scientist to Senior Scientist. Robert holds a Master of Science degree in Biochemistry and Molecular Biology from Northern Illinois University, earned between 1989 and 1996.
Location
Los Angeles, United States
This person is not in any teams
This person is not in any offices